Related Experiment Videos
Phospholipase C activity in human placental membrane
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Archives of Gynecology and Obstetrics
|January 1, 1989
Summary
This study reveals that human placenta membranes produce inositol triphosphate (IP3) via phospholipase C, indicating a key signaling pathway. This finding offers insights into placental function and potential causes of placental disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Reproductive Medicine
Background:
- Receptor-stimulated polyphosphoinositide hydrolysis by phospholipase C generates second messengers like inositol triphosphate (IP3).
- Understanding placental cell activation mechanisms is crucial for better placental function insights.
Purpose of the Study:
- To investigate inositol triphosphate (IP3) production in a cell-free human placental membrane system.
- To elucidate transmembrane signaling mechanisms in the human placenta.
Main Methods:
- Incubation of [3H]inositol-labeled human placental membranes with Ca2+, ATP, and GTP.
- Dose-dependent analysis of IP3 production.
- Comparison with [3H]arachidonic acid-labeled placental membranes to assess phospholipase A2 activity.
Main Results:
- Rapid, dose-dependent production of IP3 observed with half-maximal effect at 10 microM Ca2+.
- Minimal effect on membranes labeled with arachidonic acid, suggesting higher Ca2+ requirement for phospholipase A2.
- Direct evidence of phospholipase C activity in human placental membranes at physiological Ca2+ levels.
Conclusions:
- Human placenta possesses phospholipase C capable of hydrolyzing polyphosphoinositides at physiological Ca2+ concentrations.
- This study provides the first direct evidence of transmembrane signaling mechanisms in the human placenta.
- These findings may offer insights into the etiology of placental disorders.